Quantum Yields

**Disclosure:** I own shares of Bloom Energy (NYSE: BE). This is a follow-up to my earlier thesis post — it assumes you’ve read that one. Nothing here is financial advice. Full disclaimer at the end.

Does scale actually drive margin, or was the story priced ahead of the proof?

The test I set was whether the ~34% non-GAAP gross-margin guide would hold as revenue ramped hard. Margins expanding while volume surges is the signature of operating leverage. Margins slipping under a heavier revenue load — especially tied to deployment timing — would have been an early crack in a stock priced richly. Here’s how Q2 came in, and how I’m reading it.

The Margin Test

Non-GAAP gross margin printed 34.3%, up 604 basis points year-over-year — right around the line I’d flagged. For me that’s the number that matters most this quarter, a bit more than the revenue figure, because it’s the one the thesis actually hinged on.

The detail underneath is what I found most encouraging:

• Product gross margin: 37.2%, up 291 bps year-over-year.
• Services gross margin: 22.0%, up from 12.2% a year ago — the fifth straight quarter of double-digit service margin.

That services line is the one I keep coming back to, because it’s the part of the model I think is easy to underrate. It isn’t just “sell a box.” It’s “sell a box, then attach a decade-plus service contract behind it.” I’d argued that recurring annuity layer should compound quietly and eventually show real economics. A near-doubling of services margin year-over-year is a decent sign of that starting to happen. It’s looking more like a real profit engine and less like a slide.

The Growth Was There Too — But It’s Secondary

I don’t want to skip past the top line, because it was a genuine milestone: Bloom crossed $1 billion in quarterly revenue for the first time — $1.065 billion, up 166% year-over-year and 42% sequentially from Q1’s $751 million. Product revenue did the heavy lifting again at $935 million, up 215% year-over-year.

Sequentially, the operating leverage shows up in one glance:

Metric	Q1 2026	Q2 2026
Revenue	$751M	$1,065M
Non-GAAP gross margin	31.5%	34.3%
Non-GAAP operating margin	17.3%	22.5%
Adjusted EBITDA	$143M	$253M

Revenue up ~42% sequentially, and every margin line moving up with it. That’s the bull case in one table: as volume scales, margins expand. I’m still putting growth second, though. Explosive revenue growth was never really the open question — Bloom was already growing triple digits. The question was whether that growth was profitable and getting more so, and margin was the better tell. Growth without the margin follow-through would have left the thesis unproven.

Management Raised the Bar Again

For the second consecutive quarter, management raised full-year guidance. FY2026 revenue guidance went from $3.4–3.8B up to $3.9–4.2B, now implying roughly 100% growth over 2025. Non-GAAP operating income guidance moved to $800–900M (a ~21% implied margin, up from the 14% midpoint in the initial 2026 outlook), with EPS guidance of $2.55–2.85. The Brookfield financing framework was expanded to up to $25 billion.

A guidance raise is management putting some of its own credibility behind the ramp. Two in a row, with the margin line holding, is closer to a pattern than a single print — which is what I’d hoped to see. Sridhar’s framing on the call was that Bloom has become “a standard for on-site power in the AI market.” If that holds up, it’s Point 3 of my screen — becoming the industry standard — starting to move from thesis toward fact. Worth watching whether that language is backed by continued share gains or is getting ahead of itself.

The Part That Was Almost Too On-the-Nose

The trading action was a decent illustration of the thesis on its own. The stock fell more than 11% during the regular session before the print — dragged down in a broad AI-sector wobble — then rebounded roughly 11% after hours on the beat.

That sequence is close to the dynamic I’ve been describing: a richly valued name got sold on sentiment that had little to do with its fundamentals, right into a quarter that supported those fundamentals. It’s the thing I keep reminding myself — the business isn’t really the fragile part; the price is. The volatility tends to live in the multiple, not the operations.

It’s also the kind of setup I’ve said I’d rather act on than a euphoric run-up. I’m not chasing strength here, and one quarter doesn’t change the valuation math on its own. But a business getting cheaper on macro noise, in a quarter that answered the question I cared about, is a more interesting situation to me than paying up into a crowd’s enthusiasm.

Where That Leaves Me

My thesis is unchanged, and it now has a bit more evidence under it than a few weeks ago. The margin test I’d set out ahead of time held. The services annuity is showing better economics. Guidance went up rather than down. And the one real risk I named — valuation — is still the one real risk. The market just spent a session reminding everyone it’s there.

So the discipline stays the same: a great business and a great stock are still two different questions. The business did well against the question I was watching. The price will keep swinging on sentiment that has little to do with the fundamentals — and, for a long-term holder, that’s usually where the chances to add on weakness come from.

“Be fearful when others are greedy and greedy when others are fearful.” — W. Buffett

I said this was the number I was watching. So far, it’s holding.

Disclaimer: I own shares of BE. This post reflects my personal opinions and analysis for informational purposes only. It is not financial, investment, or tax advice, and it is not a recommendation to buy or sell any security. Figures are drawn from company filings and public reporting as of the Q2 2026 earnings release (reported July 28, 2026) and may be out of date by the time you read this. Markets involve risk, including loss of principal. Do your own research and consult a licensed professional before investing.